SBI ETF IT Share Price

Brigade Enterprises has informed that a Meeting of the Board of Directors of the Company was held as scheduled today, July 15, 2026 and the Board took the following decisions: Board has recommended the following for the approval of the shareholders in the ensuing 31st Annual General Meeting:  Considered and approved the proposal for issuance of upto 34,23,000 (Thirty Four Lakhs Twenty Three Thousand) Convertible Warrants (Warrants) convertible into 34,23,000 (Thirty Four Lakhs Twenty Three Thousand) equity shares at Rs. 526 per share (Face Value of Rs. 10 per equity share at a premium of Rs. 516 per equity share) aggregating to Rs. 180,04,98,000 (Rupees One Hundred Eighty Crores Four Lakhs Ninety Eight Thousand only) to the promoter group entity, details of which are contained in Annexure A pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. Each warrant is convertible into 1 (one) equity share and the conversion can be exercised by the warrant holder at any time within a period of 18 months from the date of allotment of warrants as the case may be, and on such terms and conditions as may be applicable. The Warrants issue is in accordance with Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018; Considered and approved issuance of Non-Convertible Debentures (NCDs) on a private placement basis in one or more tranches for an aggregate amount of up to Rs. 1500 crores (Rupees One Thousand five Hundred Crores only).

The above information is a part of company’s filings submitted to BSE.

Route Mobile has informed a meeting of the Board of Directors of Route Mobile Limited (the Company) is scheduled to be held on Thursday, July 23, 2026, inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 and any other matter with permission of the Chair. The Board shall also consider declaration of Interim Dividend, if any, for the financial year 2026-27. The Record Date for payment of Interim Dividend, if declared, will be Wednesday, July 29, 2026. The trading window of the Company has been closed from July 1, 2026 and shall remain closed till 48 hours after the declaration of the said financial results and submitted to the Stock Exchanges. The same has been informed to the Designated Persons in accordance with the above referred Code of Conduct.

The above information is a part of company’s filings submitted to BSE.

Indegene has informed that the Board of Directors of Indegene, at its meeting held on Wednesday, July 15, 2026, has, approved- The 28th Annual General Meeting (“AGM”) of the Company will be held on Thursday, 13 August, 2026 at 16:30 hours (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (OAVM), in compliance with applicable circulars issued by the Ministry of Corporate Affairs (‘MCA circulars’), and as per the provisions of the Companies Act, 2013 and Rules framed thereunder (the Act) and the SEBI Listing Regulations, to transact the business as set out in the Notice convening the AGM; As informed earlier, the Board of Directors of the Company, at its meeting held on 29 April, 2026, had recommended a final dividend of ₹2.25 per equity share of face value ₹2 each for the financial year ended 31 March 2026, subject to approval of the shareholders at the ensuing AGM. Pursuant to Regulation 42 of the SEBI Listing Regulations, the Company has fixed Friday, 31 July, 2026, as the ‘Record Date’ for determining the eligibility of Members for receiving the aforesaid final dividend, for the financial year ended 31 March 2026; Consequent to the changes in the composition of the Board of Directors, the Audit Committee, Risk Management Committee and Investment Committee have been reconstituted as follows: Appointment of Dr. Georgia Nikolakopoulou Papathomas as a Member of the Risk Management Committee and re-designation of Dr. Sanjay Suresh Parikh as the Chairperson of the Risk Management Committee ii. Appointment of Ms. Jill Mary de Simone as a Member of the Investment Committee; and iii. Cessation of Dr. Sanjay Suresh Parikh as a Member of the Audit Committee. The composition of the reconstituted committees is provided in Annexure – I. The meeting of the Board of Directors commenced at 06:00 PM (IST) and concluded at 06:21 PM (IST). The above information will be made available on the website of the Company: https://www.indegene.com/.

The above information is a part of company’s filings submitted to BSE.

Le Travenues Technology has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Coronation Fund Managers.

The above information is a part of company’s filings submitted to BSE.

Embassy Developments has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship.

The above information is a part of company’s filings submitted to BSE.